Calendar PDS Biotechnology Corporation

Equities

PDSB

US70465T1079

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.27 USD +0.31% Intraday chart for PDS Biotechnology Corporation +23.63% -34.21%

Chart calendar PDS Biotechnology Corporation

7badf20b38e80eb.LgA8tktQa7S1yz493bGqTMieZ87SKlgVjWxrhwLi0oc.RjQEhCEgXYH2vVBfhejEI4vqKbiiQR9XxRQ_wFeQnc1_dlfMIBcPjcK7dw~a11c49512bbe23d80bce92578d87f8ca

Upcoming events on PDS Biotechnology Corporation

2024-05-08 01:30 pm Investor Meeting - Key Opinion Leader
2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-13 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on PDS Biotechnology Corporation

2024-03-27 08:00 am Q4 2023 Earnings Call
2024-03-27 07:30 am Q4 2023 Earnings Release
2024-01-18 10:00 am B. Riley Securities Oncology Conference
2023-12-04 Noble Capital Markets Emerging Growth Equity Conference
2023-11-14 08:00 am Q3 2023 Earnings Call
2023-11-14 07:30 am Q3 2023 Earnings Release
2023-10-19 European Society for Medical Oncology Congress - Abstract Number : 6982
2023-10-18 03:00 am International Cytokine and Interferon Society Meeting - Ravi A. Madan
2023-10-04 02:00 pm LD Micro Main Conference
2023-10-04 02:00 pm LD Micro Main Conference
2023-10-03 08:00 am Investor Meeting - Key Opinion Leader
2023-10-01 11:00 am American Society for Radiation Oncology Meeting - Abstract Number #: 55593
2023-09-26 02:45 pm Cantor Global Healthcare Conference - Panel
2023-09-19 08:10 am European Scientific Working Group on Influenza Conference - James Allen
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 08:00 am Q2 2023 Earnings Call
2023-08-14 07:30 am Q2 2023 Earnings Release
2023-08-08 11:30 am BTIG Biotechnology Conference
2023-07-14 09:00 am Annual General Meeting
2023-06-06 08:00 am American Society of Clinical Oncology Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-20,9
-20,4
-2.63%
-14,9
-15,0
0.67%
-21,4
-22,4
4.14%
-41,7
-31,2
-33.46%
-43,0
-44,2
2.74%

-51,0

EBIT
Million USD
Released
Forecast
Spread
-21,0
-20,4
-3.11%
-14,9
-14,9
0.28%
-21,4
-22,0
2.58%
-41,7
-30,9
-35.01%
-43,0
-44,9
4.16%

-51,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
-14,8
-15,0
1.09%
-21,4
-22,4
4.32%
-42,1
-31,4
-34.09%
-44,3
-46,3
4.19%

-49,4

Net income
Million USD
Released
Forecast
Spread
0,00
0,00
-
-14,8
-14,9
0.09%
-16,9
-19,3
12.36%
-40,9
-30,3
-35%
-42,9
-44,8
4.08%

-51,0

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
-0,89
-0,84
-6.59%
-0,66
-0,71
6.6%
-1,43
-1,08
-32.06%
-1,39
-1,45
4.23%

-1,49

Announcement Date27/03/2018/03/2131/03/2228/03/2327/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-6,32
-7,25
12.82%
-8,48
-6,15
-37.87%
-7,09
-9,00
21.19%
-7,28
-8,15
10.68%
-18,8
-8,40
-124.06%
-9,42
-8,30
-13.49%
-12,7
-8,70
-45.88%
-10,5
-13,9
24.35%
-10,4
-13,1
20.36%

-11,1


-12,5


-13,3


-14,1

EBIT
Million USD
Released
Forecast
Spread
-6,32
-8,44
25.1%
-8,48
-6,56
-29.21%
-7,09
-8,38
15.36%
-7,28
-8,14
10.53%
-18,8
-8,01
-135.04%
-9,42
-9,16
-2.81%
-12,7
-10,2
-24.62%
-10,5
-14,0
24.98%
-10,4
-12,4
16.29%

-11,4


-11,8


-12,6


-13,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,32
-7,30
13.42%
-8,47
-7,05
-20.2%
-7,02
-8,70
19.33%
-7,42
-8,41
11.75%
-19,1
-8,43
-126.92%
-9,66
-9,05
-6.74%
-12,9
-10,1
-27.92%
-10,8
-14,3
24.13%
-10,9
-12,9
15.19%

-11,6


-12,0


-12,7


-13,1

Net income
Million USD
Released
Forecast
Spread
-6,32
-6,90
8.4%
-8,47
-6,56
-29.13%
-5,82
-7,46
22%
-7,42
-8,21
9.53%
-19,1
-8,54
-124.22%
-9,66
-9,39
-2.84%
-11,5
-10,5
-9.88%
-10,8
-14,6
25.78%
-10,9
-12,7
14.41%

-11,8


-12,0


-13,2


-14,1

EPS
USD
Released
Forecast
Spread
-0,23
-0,24
4.83%
-0,32
-0,23
-36.75%
-0,20
-0,28
28.99%
-0,26
-0,28
7.61%
-0,67
-0,29
-133.34%
-0,32
-0,31
-4.67%
-0,37
-0,34
-8.82%
-0,35
-0,45
21.47%
-0,35
-0,41
14.63%

-0,37


-0,36


-0,38


-0,38

Announcement Date31/03/2211/05/2208/08/2214/11/2228/03/2315/05/2314/08/2314/11/2327/03/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PDSB Stock
  4. Calendar PDS Biotechnology Corporation